Related Experiment Videos
Infectious mononucleosis complicated by severe Mycoplasma pneumoniae infection
Abstract:
A 14-year-old girl with infectious mononucleosis and secondary immunosuppression had severe dyspnea and cough, spiking fever, rales, and diffuse bilateral pulmonary infiltrates. The pulmonary disease progressed rapidly, necessitating empiric trials of antimicrobial agents. Mycoplasma pneumoniae was isolated from a lung biopsy specimen, transtracheal aspirate, and expectorated sputum, but the relatively long period required to isolate the organism delayed the microbiologic diagnosis. Serologic study of acute and convalescent serum samples confirmed the M pneumoniae infection. Clinical improvement was gradual, and the immunosuppression was transient. The patient's illness appeared to represent microbial synergism, with severe M pneumoniae infection complicating transient immunosuppression induced by infectious mononucleosis.
Insights
Infectious mononucleosis can cause immunosuppression, leading to severe Mycoplasma pneumoniae pneumonia. Early diagnosis and treatment are crucial for managing this serious respiratory illness.
Area of Science:
- Pulmonology
- Infectious Diseases
- Immunology
Background:
- Infectious mononucleosis, a common viral illness, can transiently suppress the immune system.
- Secondary immunosuppression increases susceptibility to opportunistic infections.
- Severe pulmonary infections require prompt diagnosis and management.
Observation:
- A 14-year-old girl with infectious mononucleosis developed severe pneumonia with respiratory distress.
- Pulmonary infiltrates progressed rapidly, necessitating empiric antimicrobial therapy.
- Mycoplasma pneumoniae was identified in respiratory samples, but diagnosis was delayed.
Findings:
- Mycoplasma pneumoniae was confirmed as the causative agent of severe pneumonia.
- The patient experienced gradual clinical improvement with treatment.
- Transient immunosuppression from mononucleosis likely predisposed to severe M. pneumoniae infection.
Implications:
- This case highlights the potential for severe M. pneumoniae pneumonia in immunocompromised individuals.
- Microbial synergism between viral and bacterial infections can lead to severe outcomes.
- Prompt microbiologic diagnosis and targeted therapy are essential for managing severe respiratory infections in immunocompromised patients.